These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17386905)

  • 21. [Discovery and significance of natriuretic peptides].
    Nakao K; Tamura N
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():5-9. PubMed ID: 15506327
    [No Abstract]   [Full Text] [Related]  

  • 22. Vasoactive peptides in cardiovascular (patho)physiology.
    Callera G; Tostes R; Savoia C; Muscara MN; Touyz RM
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):531-52. PubMed ID: 17489676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natriuretic peptides - physiology, pathophysiology and clinical use in heart failure.
    Krupicka J; Janota T; Kasalová Z; Hradec J
    Physiol Res; 2009; 58(2):171-177. PubMed ID: 18380534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U; Wollert KC; Drexler H
    Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin receptor blockers: novel role in high-risk patients.
    Javed U; Deedwania PC
    Cardiol Clin; 2008 Nov; 26(4):507-26. PubMed ID: 18929228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The natriuretic peptide system: kidney and cardiovascular effects.
    Silver MA
    Curr Opin Nephrol Hypertens; 2006 Jan; 15(1):14-21. PubMed ID: 16340661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Natriuretic peptides in clinical practice].
    Urek R; Cubrilo-Turek M
    Acta Med Croatica; 2008 Feb; 62(1):53-6. PubMed ID: 18365500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardioprotective effects of natriuretic peptides].
    Horio T
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():65-8. PubMed ID: 15506339
    [No Abstract]   [Full Text] [Related]  

  • 29. [New applications of erythropoietin in cardiovascular disease: from haematopoiesis to cardiac protection].
    van der Meer P; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(16):923-7. PubMed ID: 18561787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence.
    Dhar S; Pressman GS; Subramanian S; Kaul S; Gollamudi S; Bloom EJ; Figueredo VM
    Postgrad Med J; 2009 Jun; 85(1004):299-302. PubMed ID: 19528304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac fibroblasts: at the heart of myocardial remodeling.
    Porter KE; Turner NA
    Pharmacol Ther; 2009 Aug; 123(2):255-78. PubMed ID: 19460403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natriuretic peptides in heart failure: empathizing with the sobbing heart..
    Narula J; Young JB
    Heart Fail Clin; 2006 Jul; 2(3):xi-xiii. PubMed ID: 17386893
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of long-term B-type natriuretic peptide treatment on left ventricular remodeling and function after myocardial infarction in rats.
    He J; Chen Y; Huang Y; Yao F; Wu Z; Chen S; Wang L; Xiao P; Dai G; Meng R; Zhang C; Tang L; Huang Y; Li Z
    Eur J Pharmacol; 2009 Jan; 602(1):132-7. PubMed ID: 19027731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insights into the role of natriuretic peptides in the regulation of apoptosis in cardiovascular system.
    Gao P; Huang L
    Saudi Med J; 2009 May; 30(5):595-604. PubMed ID: 19417955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiology 2008].
    Hoppe UC; Erdmann E
    Dtsch Med Wochenschr; 2008 Jun; 133(25-26):1341-3. PubMed ID: 18553258
    [No Abstract]   [Full Text] [Related]  

  • 36. Targeting histone deacetylases for heart failure.
    Bush EW; McKinsey TA
    Expert Opin Ther Targets; 2009 Jul; 13(7):767-84. PubMed ID: 19466913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.
    Bartha E; Kiss GN; Kalman E; Kulcsár G; Kálai T; Hideg K; Habon T; Sumegi B; Toth K; Halmosi R
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):253-61. PubMed ID: 18806606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natriuretic peptides and renal insufficiency: clinical significance and role of renal clearance.
    Freda BJ; Francis GS
    Heart Fail Clin; 2006 Jul; 2(3):277-90. PubMed ID: 17386897
    [No Abstract]   [Full Text] [Related]  

  • 39. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
    Fraccarollo D; Widder JD; Galuppo P; Thum T; Tsikas D; Hoffmann M; Ruetten H; Ertl G; Bauersachs J
    Circulation; 2008 Aug; 118(8):818-27. PubMed ID: 18678774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac surgery as a cause of acute kidney injury: pathogenesis and potential therapies.
    Rosner MH; Portilla D; Okusa MD
    J Intensive Care Med; 2008; 23(1):3-18. PubMed ID: 18230632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.